Workstream Type: Informing Dialogue
-
Medicare Part B Premium Dynamics Explained
Read More
-
Evaluating Industry’s Drug Pricing Claims
Read More
-
Mapping conflict of interests: scoping review
Read More
-
Production Plus Profit Pricing (P-quad) FAQ
Read More
-
Medicare Must Study Unproven, Expensive Alzheimer’s Drug
Read More
-
Trump’s Drug-Pricing Ideas Would Cost Taxpayers a Bundle
Read More
-
We can’t tackle the pandemic without figuring out which Covid-19 vaccines work the best
Read More
-
Instead of debating ‘first-shot’ vs ‘set-aside’ vaccine approaches, hospitals’ study should compare them
Read More
-
CMS’s Proposed Medicaid Best Price Loophole for Value-Based Purchasing of Drugs
Read More
-
The Science on Coronavirus is Topsy-Turvy. That’s Fine.
Read More